Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» weight loss
weight loss
Amgen’s Weight-Loss Drug Candidate Shows Promise in Early Data
BioSpace
Mon, 02/5/24 - 11:04 pm
Amgen
weight loss
clinical trials
MariTide
Could Novo, Lilly become first trillion-dollar healthcare companies?
Pharma Voice
Mon, 02/5/24 - 10:30 am
Novo Nordisk
Eli Lilly
Ozempic
Wegovy
Mounjaro
obesity
weight loss
Could Abbott Labs Be the Next Big Winner in the Billion-Dollar Weight Loss Market?
Motley Fool
Fri, 02/2/24 - 11:50 am
Abbott Labs
Novo Nordisk
Eli Lilly
weight loss
Protality
Drugmakers explore muscle loss prevention when taking weight loss drugs
Beckers Hospital Review
Tue, 01/23/24 - 11:06 am
weight loss
muscle
Ozempic
Wegovy
Eli Lilly
Regeneron
FDA says no evidence yet linking weight loss drugs to suicidal thoughts
Reuters
Thu, 01/11/24 - 11:35 am
Novo Nordisk
Eli Lilly
weight loss
GLP-1 agonist
FDA
Tennessee company in battle with European regulators over weight-loss drug
Axios
Tue, 12/19/23 - 10:25 am
Currax
Europe
weight loss
Contrave
Mysimba
Ozempic
Obesity drug Mounjaro to surpass Ozempic with $27 billion sales in 2029
Biopharma Reporter
Mon, 12/18/23 - 11:37 am
Eli Lilly
Novo Nordisk
obesity
weight loss
Ozempic
Mounjaro
Caliway secures funding to progress fat reduction drug trial
Clinical Trials Arena
Mon, 12/18/23 - 10:13 am
Caliway
clinical trials
CBL-514
weight loss
IndiaMART is working with Novo Nordisk to halt illegal Wegovy sales -source
Reuters
Sun, 12/17/23 - 09:57 pm
India
Novo Nordisk
Wegovy
weight loss
US employers hire virtual providers as weight-loss drug gatekeepers
Reuters
Wed, 12/13/23 - 09:38 am
Novo Nordisk
Wegovy
weight loss
Teladoc
Lilly Stock Slips as Patients Regain Weight After Stopping Zepbound
BioSpace
Mon, 12/11/23 - 10:58 pm
Eli Lilly
weight loss
Zepbound
GLP-1 agonist
Could Eli Lilly Beat Novo Nordisk in the Billion-Dollar Weight Loss Market?
Motley Fool
Fri, 12/8/23 - 09:56 am
Eli Lilly
Novo Nordisk
weight loss
Wegovy
Zepbound
Adherence to weight-loss drugs is far higher with Wegovy than older medicines
Reuters
Wed, 12/6/23 - 10:36 am
Wegovy
Novo Nordisk
weight loss
patient adherence
As Ozempic cases mount, consumer lawyers push to consolidate lawsuits
Reuters
Mon, 12/4/23 - 06:05 pm
legal
weight loss
Ozempic
Wegovy
Novo Nordisk
side effects
Roche joins obesity drug chase with $2.7B deal for startup Carmot
BioPharma Dive
Mon, 12/4/23 - 10:18 am
Roche
Carmot Therapeutics
weight loss
obesity
M&A
Demand for Ozempic and Wegovy Is Through the Roof. Here's Why it Can Go Even Higher.
Motley Fool
Wed, 10/25/23 - 09:51 am
Novo Nordisk
Ozempic
Wegovy
diabetes
weight loss
Belgium plans temporary ban on use of Ozempic for weight loss
Yahoo/Reuters
Tue, 10/24/23 - 09:39 am
Novo Nordisk
Ozempic
diabetes
weight loss
Belgium
drug shortages
Are Weight-Loss Drugs the da Vinci Robot’s Newest Competitor?
Medical Devices and Diagnostics Industry
Sun, 10/22/23 - 06:09 pm
Medtech
weight loss
Intuitive Surgical
robotic surgery
Lilly’s Tirzepatide Shows Strong Weight Loss Efficacy in Phase III Study
BioSpace
Mon, 10/16/23 - 10:17 am
Eli Lilly
tirzepatide
weight loss
clinical trials
Fresenius Medical: effect of drugs like Ozempic on patient numbers is neutral
Yahoo/Reuters
Thu, 10/12/23 - 05:24 pm
Fresenius Medical Care
Ozempic
diabetes
weight loss
Novo Nordisk
dialysis
Medtech
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »